title: Epoetin-induced autoimmune pure red cell aplasia.
authors.affiliation: Hôpital Hôtel-Dieu, Paris, France.
authors.forename: Nicole
authors.initials: N
authors.lastname: Casadevall
mesh_terms: D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D002626:Chemistry, Pharmaceutical; D004340:Drug Contamination; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D011379:Prognosis; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D012307:Risk Factors; D013012:Sorbitol / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; D013012:Sorbitol; D000068817:Epoetin Alfa